Bandhan Mutual Fund has launched the Bandhan Healthcare Fund, an open-ended equity scheme aimed at capitalizing on India’s rapidly expanding healthcare sector. The New Fund Offer (NFO) opens on November 10 and closes on November 24, 2025. The fund will invest across hospitals and diagnostics, pharmaceuticals, biotechnology, wellness, health-tech, and allied services.
Vishal Kapoor, CEO of Bandhan AMC, said, “Healthcare is one of the most enduring growth themes. As India’s population ages and medical innovation accelerates, healthcare spending is set to grow significantly. The Bandhan Healthcare Fund offers investors a disciplined and diversified way to participate in this structural transformation.” Fund manager Viraj Kulkarni outlined the investment approach, stating the portfolio will be diversified across four key themes: Hospitals & Diagnostics, Export CDMO/API, Export Generics, and Domestic Branded Formulations, with each contributing 20–30% to the fund. The focus will be on companies with scalable business models, strong balance sheets, and consistent profitability.
In Kolkata, investors and wealth advisors have welcomed the launch, noting the city’s growing appetite for sector-specific funds. Local distributors report strong interest from retail and HNI investors seeking long-term growth opportunities in healthcare, particularly in a market where awareness of mutual fund options continues to rise. The fund is positioned for investors with a long-term horizon seeking exposure to India’s dynamic healthcare ecosystem.